Table 3 : Serum and urinary biochemical parameters*, †, ‡.


Group
Items/Normal range 1 2 3 4 5 6 7 8
CTL AAM QT AAM+QT DM DM+ AAM DM+ QT DM+ AAM+ QT
Serum Ab(g/dL)(3.8-5.4) 4.5±0.2 5.1±0.3& 4.4±0.1 4.7±0.2 3.2±0.1& 3.8±0.1&∂ 3.0±0.1& 3.3±0.1&
TG mg/dL 75±15 75±15 81±5 75±5 120±20 103±17 255±45 553±75
BUN(mg/dL)(15-21) 16±2 20±3& 18±2 22±3& 30±5& 28±3& 27±2& 29±4&
NUU(mg/dL) 55±6 77±6& 60±8 80±7& 147±9& 158±8& 131±4&∂ 121±6&∂
PTur(mg/dL)(<100) 24±6 88±5& 36±5& 78±7& 189±6& 256±8&∂ 137±8&∂ 121±8&∂

*Measured on urine collected the first day after different treatments.
†Data expressed in mean±SD (n=8).
‡The symbol "&" in the same row indicate significant difference from the normal control (p<0.05). The symbol
"∂" in the same row indicates significant difference among the DM-related groups taking the DM rats as the
reference.
Dose: ip Moriamin 1.6 mL/rat-day. QT ip treated control (70 mg/kg-day, suspended in PBS).

Chen et al.Journal of Diabetes Research and Clinical Metabolism  2014 3:5DOI : 10.7243/2050-0866-3-5